Quantcast

Latest Memorial Sloan–Kettering Cancer Center Stories

2010-11-01 21:58:10

Memorial Sloan-Kettering Cancer Center study extends lung cancer scope to children and adolescents Because primary lung adenocarcinoma is exceedingly rare in the pediatric population, it is difficult to properly classify certain lung tumors in children and adolescents. While anecdotal reports of pediatric patients with lung cancer lesions exist, little research has been conducted to link the disease in children to similar pulmonary malignancies in adults. Through an assessment of clinical,...

2010-10-29 18:46:19

An international study led by researchers at Memorial Sloan-Kettering Cancer Center has identified genetic variants in women with BRCA2 mutations that may increase or decrease their risk of developing breast cancer. The study was published today online in the open-access journal PLoS Genetics. The findings of the study suggest that genetic variants on chromosomes 10 and 20 may modify risk for breast cancer among women with a BRCA2 mutation. Researchers analyzed DNA samples from 6,272 women...

2010-10-25 12:51:53

Minority patients have a significantly decreased survival from colon cancer compared to white patients, most often as a result of a late diagnosis. To help address this problem, a team of healthcare professionals at Memorial Sloan-Kettering Cancer Center has identified an efficient way to increase minority access to lifesaving colorectal cancer screening (CRCS) in communities where multiple barriers to preventive care exist. In the November 8 issue of the journal Cancer, the group reports how...

2010-10-25 11:57:00

HACKENSACK, N.J., Oct. 25 /PRNewswire/ -- The John Theurer Cancer Center at Hackensack University Medical Center unveiled a new $130-million, 155,000-square-foot comprehensive cancer facility that will enhance the cancer center's ability to deliver multidisciplinary extraordinary care, best-in-class clinical quality, and cutting-edge research. The doors will open for patients in January 2011. (Photo: http://photos.prnewswire.com/prnh/20101025/NY87550 ) (Photo:...

2010-10-19 11:29:00

NEW YORK, Oct. 19 /PRNewswire/ -- The largest donation in the Lung Cancer Research Foundation's (LCRF, www.lungfund.org) history was announced in New York today by LCRF founder Laurie C. Carson. In announcing the 2.1 million dollar donation, Ms. Carson said, "The impact that this gift has on the Foundation at this critical point in our growth is enormous. It is a transformational gift and it enables us to expand our grant program in a very meaningful and measurable way." Lung cancer is the...

2010-10-01 14:08:31

Discovery shows that activating rearrangements in receptor genes are more common than previously thought A multi-institutional team led by investigators from Memorial Sloan-Kettering Cancer Center has published a study that provides new insight into genetic changes that make some forms of glioblastoma, the most common type of primary brain cancer, more aggressive than others and explains why they may not respond to certain therapies. The research was led by senior author Eric C. Holland, MD,...

2010-09-27 15:45:00

NEW YORK, Sept. 27 /PRNewswire-USNewswire/ -- The T.J. Martell Foundation for Leukemia, Cancer and AIDS Research will honor several leaders at its 35th Annual Awards Gala on Wednesday, October 27th, 2010 at the Marriott Marquis Times Square in Manhattan. "All cancers kill approximately 550,000 Americans every year. That means one person dies every minute. It used to be two people every minute," says Founder and Chairman Tony Martell. "This is an issue that must be addressed more...

92ab64a45cdc85b25c12047a3c22d96d1
2010-09-15 09:20:10

A blood test at the age of 60 can accurately predict the risk that a man will die from prostate cancer within the next 25 years, according to researchers at Memorial Sloan-Kettering Cancer Center, in New York, and Lund University, in Sweden. The findings, published Sept. 14 online in the British Medical Journal, could have important implications for determining which men should be screened after the age of 60 and which may not benefit substantially from continued prostate cancer screening....

2010-09-09 01:10:08

A team of scientists, led by University of California, San Diego School of Medicine researchers, has synthesized hundreds of new compounds with the potential of reducing the production of the A-beta 42 peptide, a primary component of Alzheimer's disease (AD). In mouse models, one tested compound specifically reduced levels of A-beta 42, which is believed to be responsible for the destruction of neurons, but left other essential enzymatic activities in the brain unaffected, said Steven Wagner,...

2010-08-26 14:03:25

A multicenter study has concluded that treatment with a new targeted therapy called PLX4032 (also called RG7204) resulted in significant tumor shrinkage in 80 percent of patients with advanced melanoma. Investigators at Memorial Sloan-Kettering Cancer Center and colleagues at other cancer centers have published their findings in the August 26 edition of the New England Journal of Medicine. "Metastatic melanoma is a very challenging disease to treat and there have been no significant...


Word of the Day
mundungus
  • A stinking tobacco.
  • Offal; waste animal product; organic matter unfit for consumption.
This word comes from the Spanish 'mondongo,' tripe, entrails.